Organon (OGN) Other Accumulated Expenses (2023)

Organon (OGN) posted quarterly Other Accumulated Expenses of $1.0 million for Q4 2023.

Organon (OGN) Other Accumulated Expenses (2023) Analysis & Trends

Organon (OGN) has reported Other Accumulated Expenses for 1 consecutive years, with $1.0 million the latest figure, recorded in Q4 2023.

In Q4 2023, Other Accumulated Expenses changed N/A year-over-year to $1.0 million; the TTM figure through Dec 2023 stood at $1.0 million (changed N/A YoY), while the FY2023 annual figure was $1.0 million, changed N/A from the prior year.
Other Accumulated Expenses came in at $1.0 million for Q4 2023 at Organon.
The five-year high for Other Accumulated Expenses was $1.0 million in Q4 2023, with the low at $1.0 million in Q4 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Organon	3.53 Bn	2.41 Bn	783.00 Mn

Historic Data

Download Data

Date	Value
Dec 31, 2023	1.00 Mn